Ahead of the anticipated CDC release of revised U.S. H1N1 (swine flu) death toll estimates, Reuters examines how the agency and WHO measure the impact of the virus, after both organizations “stopped trying to count actual cases months ago, once it became clear that H1N1 was a pandemic that would infect millions.”
Drugmaker GlaxoSmithKline announced plans on Tuesday to donate 50 million doses of its H1N1 (swine flu) vaccine to the WHO for use in developing countries within the next few months, Reuters reports.
Also In Global Health News: Nutritionally-Enhanced Products; Health Care In India; Cell Phones As Microscopes; GSK Pneumonia Vaccine; Men Fighting HIV/AIDS
News Outlets Examine Nutritionally-Enhanced Products The East African examines the recent launch of a $21.25 million research project, at the International Sweet Potato Centre in Uganda, that aims to develop “nutritionally enhanced sweet potatoes â€¦ to reduce health problems related to vitamin A deficiency and improve food security in sub-Saharan…
The WHO on Friday reported on a rising number of H1N1 (swine flu) cases in China and Japan, Reuters/Washington Post reports. “In China, after an earlier wave of mixed influenza activity (seasonal H3N2 and pandemic H1N1), pandemic H1N1 influenza activity now predominates and is increasing,” the agency said. “Sharp increases in pandemic flu infections continue to be reported throughout Japan, particularly on the northern island,” the news service writes (Nebehay, 11/6).
The 5th Multilateral Initiative on Malaria (MIM) Pan-African Conference ended Friday in Nairobi, Kenya, “with scientists expressing optimism about several developments in the works to prevent, treat, and possibly eradicate a disease that kills nearly one million people in Africa each year,” VOA News reports.
Clinical Infectious Diseases Examines Malaria Treatment An editorial commentary appearing in Clinical Infectious Diseases examines the insight gained in how best to control malaria, based on recent studies of artemisinin combination therapy (ACTs). “As we move toward the elimination of malaria, it is crucial that policymakers and research groups endorse…
The H1N1 (swine flu) virus is now the dominant flu strain worldwide, the WHO reported Thursday, with the virus accounting for up to 70 percent of the flu viruses sampled in some countries, the Associated Press reports. “We remain quite concerned about the patterns that we’re seeing,” Keiji Fukuda, the WHO’s Special Adviser on Pandemic Influenza to the Director-General, said during a press briefing.
Wall Street Journal Examines Big Pharma’s ‘Growing Interest’ In Emerging-Market Vaccine Development, Production
The Wall Street Journal examines “big pharma’s growing interest in a corner of healthcare â€“ emerging-market inoculations,” in light of a recent move by Novartis to purchase an 85 percent stake in the Chinese vaccine maker Zhejiang Tianyuan Bio-Pharmaceutical Co.
U.S. health officials briefing Congress on Wednesday would not outline a timeframe for when enough H1N1 (swine flu) vaccines would be available to reach all high-risk populations in the country, the Washington Post reports.
In a session at the 5th Multilateral Initiative on Malaria (MIM) Pan-African Conference in Nairobi, Kenya, experts discussed the tools required to eradicate the disease and highlighted insecticide and drug resistance in some parts of the world, Xinhua reports.